About the Site Authors
This website is provided for you by Choice and Medication©, and is run by Mistura Enterprise Ltd®, a fiercely independent organisation run by highly qualified professionals and specialists in mental health and mental health medicines. All income comes from subscriptions from subscribing organisations, with no income or support from any Pharmaceutical Industry or other commercial sources.
Professor Stephen Bazire BPharm, DipPsychPharm, FRPharmS, FCMHP, GHP Gold Medal 2012, MBE is an Honorary Professor, School of Pharmacy, University of East Anglia in Norwich, a Fellow of the Royal Pharmaceutical Society of Great Britain, was awarded an MBE in 2010 for services to pharmacy, and awarded the Guild of Healthcare Pharmacists Gold Medal in 2013 for outstanding contributions to pharmacy in the NHS. Until he fully retired from the NHS in 2015, he was a Consultant Pharmacist (GPhC number 2022821) for Norfolk and Suffolk NHS Foundation Trust (having been Chief Pharmacist there from 1986 to 2011).
Steve is an internationally known speaker on several topics (e.g. ADHD, Medication Choice, psychosis, Bipolar Disorder and others). He has been Chairman and Council Member of the College of Mental Health Pharmacy, a member of the Council of British Association for Psychopharmacology, Visiting Fellow and External Examiner for the School of Pharmaceutical Sciences, Aston University in Birmingham, a Trustee of Mind in Norfolk (2014-2021), a member of Drug Science, and Bipolar UK's Clinical Advisory Group. He also led the successful implementation of automation and electronic prescribing in his mental health pharmacy service.
Stephen Bazire is a Director of Mistura Enterprise Ltd® (Choice and Medication©) and Mistura Informatics Ltd® (MaPPs 2©/WMD?), and he has led content development for the Choice and Medication© website since it was launched in 2008. This provides information in a variety of ways including online formats and downloadable leaflets, because "one size does not fit all".
Professor Bazire is probably best known as the author of the “Psychotropic Drug Directory“, of which there have been 31 editions (latest 2020/1), with over half a million copies sold worldwide. He has now stepped down as sole author and the book is moving to the Pharmaceutical Press.
Dr. Dawn Price is a registered independent prescribing specialist pharmacist (GPhC number 2039501). She has over 15 years senior management and clinical experience in Secondary Care Pharmacy, Substance Misuse, Clinical Justice and Specialist Mental Health Pharmacy. In addition, Dawn has extensive experience in primary care, working in community pharmacy and managing medication review clinics in general practice as well as being one of the first medicines management pharmacists, (BMJ 2000).
Dawn is well known for working at a national level as the Royal Pharmaceutical Society expert representative for Substance Misuse working with Public Health England for both the review of the UK Clinical Guidelines (The Orange Guidelines) and the Non-Medical Prescribing in Substance Misuse Guidelines. Committee Member of the steering group for the NMPSM (Non-Medical Prescribing in Substance Misuse), Committee Member of College of Mental Health Pharmacy (2009-2010) and was Vice Chair of UK Psychiatric Pharmacy Group (2007-2009). Previous positions held include National Chief Pharmacist and Non-Medical Prescribing Lead at Addaction (2011-2016), Deputy Chief Pharmacist at Northumberland Tyne and Wear NHS Foundation Trust (2009-2011), Chief Pharmacist, Cheshire and Wirral Partnership NHS Foundation Trust (2008-2009), Chief Pharmacist South of Tyne and Wearside Mental Health Trust (2004-2008).
Dawn’s IT research interests now lie in HCD (Human Computer Design), applying usability testing of health information systems to ensure they are both usable, have utility (useful) and positive health outcomes. As a result Dawn has researched the positive impact on medicine adherence following intervention with the Choice and Medication© health information website for patients with mental health conditions. In the past, Dawn has also project managed the deployment of web based pharmacy systems, e-prescribing systems and e-learning systems within Healthcare Organisations. This includes deployment of near patient testing analysers in a novel service for patients on clozapine with added value for health supported by independent prescribing clinical pharmacists. Following presentation at the European Association for Hospital Pharmacy (EAHP) in 2007 this is now standard practice for mental health pharmacy.
Dawn is Managing Director of both Mistura Enterprise Ltd® (Choice and Medication©) and Mistura Informatics Ltd® (MaPPs 2©) and is responsible for all aspects of running the IT company and managing the ever growing clinical and operational teams.
Business Operations Manager
Lisa Yates is the Business Operations Manager for both Mistura Enterprise Ltd® and Mistura Informatics Ltd® working on the Choice and Medication© website and MaPPs 2©. Lisa also coordinates and manages the 3 teams across the UK in order to ensure the software is both functional and up-to-date. Lisa is based at our company administrative headquarters in Ashington on the South East Northumberland Coastline. We occasionally let out of her cage for conferences as long as promises to behave. So far so good…
Hazel is an Advanced Clinical Pharmacist (Medicines Information), for Tees, Esk and Wear Valleys NHS Foundation Trust, based at Roseberry Park Hospital, Middlesbrough. Hazel joined us in April 2022 and is our "Radar", keeping us up-to-date with developments.
Deb joined us in July 2022 and most recently worked as clinical pharmacist for Honiton, Ottery St Mary and Sidmouth PCN, having been with Somerset Partnership NHS Trust before that. Deb is our "Rolling Review" specialist, going through existing resources on a rolling basis so nothing gets let behind.
No one connected with this website stands to gain anything whatsoever as a result of any decisions or choices you make as a result of reading the content of the website. We are fiercely independent. Our funding comes purely from subscriptions, with no Pharma Industry or other influence whatsoever.
This isn’t true of all websites so beware of sites where there can be a hidden potential bias.